Independence Day hours

Independence Day, Friday, July 4: ARC Far West, ARC Round Rock, and ARC Southwest After Hours Clinics will be open 8am - 5pm on Independence Day, Friday, July 4. All other ARC clinics will be closed in observance of Independence Day.

Measles - Local update

Local health departments have not recommended additional vaccination beyond current guidelines. Texas health officials urge immunization to protect against and prevent the spread of measles. ARC has received additional vaccines for children and adults to keep the community protected. Read our measles vaccination guidelines.

Visit the DSHS website to track the current outbreak in Texas.

Pertussis - Local update

Pertussis, also known as whooping cough, is circulating in our area. The best thing you can do to guard your health against pertussis is check that you are up to date on your Tdap or DTap vaccines. If you suspect you may have contracted pertussis or came into contact with someone who was diagnosed, you should schedule an appointment with your primary care doctor or advanced practice clinician (APC). Read our pertussis local update.

MyChart Login Help Me Book

Enrolling Studies

The research team at ARC is currently managing several different clinical studies. Are you interested in a particular study opportunity? Information about current study opportunities currently enrolling patients can be found below. Both ARC patients and non-ARC patients who fit the trial eligibility requirements are welcome.

  • BaxDuo Arctic Chronic Kidney Disease (CKD) Clinical Study

    A phase III, randomized, double-blind, active-controlled study intended to assess the efficacy, safety, and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on chronic kidney disease (CKD) progression in participants with CKD and high blood pressure.

    About the Study

  • BaxDuo Pacific Chronic Kidney Disease (CKD) Clinical Study

    A phase III, randomized, double-blind, active-controlled study intended to assess the efficacy, safety, and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on chronic kidney disease (CKD) progression and cardiovascular events in participants with CKD and high blood pressure.

    About the Study

  • Chronic Spontaneous Urticaria (CSU) Clinical Study

    This is a multi-center, phase 2b, randomized, placebo-controlled, dose-ranging study evaluating the efficacy and safety of EV0756 in subjects with moderate to severe CSU (chronic spontaneous urticaria).

    About the Study

  • Clinical Biospecimen Collection for Alzheimer's & Parkinson's Disease Biomarker Research

    Biospecimen collection for subjects with clinically established Alzheimer's or Parkinson's disease to support biomarker research. Must be willing to undergo a one-time blood draw and urine collection.

    About the Study

  • ENABLE Multiple Sclerosis (MS) Clinical Study

    A long-term observational registry study for patients with multiple sclerosis (MS) to collect real-world data on BRIUMVI (infusion medication) and assess efficacy, safety, and tolerability of medication.

    About the Study